These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9122996)

  • 1. In vivo hyperexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine.
    Shin GT; Khanna A; Sharma VK; Ding R; Azizlerli S; Li B; Suthanthiran M
    Transplant Proc; 1997; 29(1-2):284. PubMed ID: 9122996
    [No Abstract]   [Full Text] [Related]  

  • 2. Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?
    el-Gamel A; Awad M; Yonan N; Keevil B; Egan J; Campbell C; Rahman AN; Haselton P; Deiraniya AK; Hutchinson IV
    Transplant Proc; 1998 Jun; 30(4):1525-7. PubMed ID: 9636621
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.
    Shin GT; Khanna A; Ding R; Sharma VK; Lagman M; Li B; Suthanthiran M
    Transplantation; 1998 Feb; 65(3):313-8. PubMed ID: 9484745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic monitoring of lymphocyte proliferation and TGF-beta 1 expression at cyclosporine a (CyA) trough levels (C(0)) and 2 hours after intake (C(2)) of CyA in human renal allograft recipients.
    Böhler T; Budde K; Schneider M; Eliazyfer S; Dell K; Einecke G; Diekmann F; Fritsche L; Mai I; Neumayer HH; Waiser J
    Transplant Proc; 2001; 33(7-8):3148-50. PubMed ID: 11750352
    [No Abstract]   [Full Text] [Related]  

  • 5. Transforming growth factor-beta1 plasma levels in stable renal allograft recipients under different immunosuppression.
    Hetzel GR; Plum J; Ozcan F; Heering P; Grabensee B
    Transplantation; 2001 Feb; 71(4):586-7. PubMed ID: 11258445
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression.
    Miyagi M; Muramatsu M; Ishikawa Y; Ishii T; Sakai K; Arai K; Aikawa A; Ohara T; Mizuiri M; Hirayama N; Hasegawa A
    Transplant Proc; 2002 Aug; 34(5):1589-90. PubMed ID: 12176497
    [No Abstract]   [Full Text] [Related]  

  • 7. Is TGF-beta a profibrotic cytokine in human renal transplants?
    Nicholson ML; Bicknell GR; Williams ST; Furness PN
    Transplant Proc; 1998 Jun; 30(4):952. PubMed ID: 9636384
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G; Perico N; Gaspari F
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic considerations in the therapeutic application of cyclosporine in renal transplantation.
    Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2143-6. PubMed ID: 8769182
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine.
    Khanna AK; Hosenpud JS; Plummer MS; Hosenpud JD
    Transplantation; 2002 May; 73(10):1543-9. PubMed ID: 12042638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of cyclosporine therapy in renal transplantation.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1718-20. PubMed ID: 9723254
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin: nephro-protective as well as nephrotoxic?
    Mathieson PW
    Clin Exp Immunol; 2000 Aug; 121(2):179-80. PubMed ID: 10970156
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients.
    Pozzetto U; Citterio F; Romagnoli J; Scatà M; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1740-2. PubMed ID: 12176558
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
    Abella I
    Transplant Proc; 1996 Dec; 28(6):3131-4. PubMed ID: 8962213
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine: the principal immunosuppressant for renal transplantation.
    Keown PA; Primmett DR
    Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
    [No Abstract]   [Full Text] [Related]  

  • 18. An expression of T-lymphocyte subset phenotype postrenal transplantation: feasibility for tailored individualized immunosuppressive therapy.
    Jun Q; Li ; Yushan L; Ming Z; Zhilian M
    Transplant Proc; 2003 Feb; 35(1):240-2. PubMed ID: 12591381
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
    Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J
    Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.